Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page
- Check5 days agoChange DetectedThe study's record history now includes a new revision entry, v3.6.3, indicating an updated version of the record. The history diff also shows the previous revision v3.6.2 as removed from the displayed entries.SummaryDifference0.1%

- Check12 days agoChange DetectedAn updated revision entry, v3.6.2, was added to the study record history. It replaces the previous v3.6.0 entry, signaling a newer release of the record.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history now shows that recruitment has ended for the study ('No longer looking for participants'). A new release note 'Revision: v3.6.0' was added and the previous release 'Revision: v3.5.5' was removed.SummaryDifference0.4%

- Check33 days agoChange DetectedThe history page now shows a new site revision, v3.5.5, replacing the previous v3.5.4. This indicates an underlying platform update or deployment behind the page, not changes to trial data.SummaryDifference0.1%

- Check48 days agoChange DetectedThe revision label on the history page updated from v3.5.3 to v3.5.4, indicating a new site release was deployed behind the page. This reflects a backend update rather than a change to trial information.SummaryDifference0.1%

- Check69 days agoChange DetectedNew entry added: revision v3.5.3. The corresponding deletion shows v3.5.2 is superseded, reflecting a page version update.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.